Pharma & Biotech

Sangamo Therapeutics finds itself navigating perilous financial waters, with its stock experiencing a dramatic 21% decline following disappointing quarterly results...

Viking Therapeutics has captured significant market attention following the release of impressive clinical trial results for its obesity treatment candidate...

The pharmaceutical sector is witnessing unprecedented excitement around innovative obesity treatments, with Eli Lilly positioned squarely at the epicenter of...

A significant trade barrier has been partially dismantled for genomics leader Illumina. After months of restricted access, Chinese authorities have...

Shares of animal health company Zoetis experienced a dramatic sell-off on November 4th, plummeting 13.78 percent to establish a new...

Geron Corporation witnessed a significant sell-off in its stock price on Friday, with shares declining by more than 9%. This...

Shares of Denali Therapeutics experienced significant volatility recently, declining more than 9% during a turbulent trading week. The biopharmaceutical company...

Gilead Sciences finds itself at a critical investment juncture as conflicting developments within its pharmaceutical pipeline create uncertainty for shareholders....

Investors in Arrowhead Pharmaceuticals are bracing for significant volatility as the biotechnology firm approaches two major regulatory events that could...

Intellia Therapeutics shares experienced a severe downturn on Friday, plummeting 22.7% as investors reacted to a devastating combination of clinical,...